PURE Bioscience, Inc. (PURE) Reports Q3 Loss of $0.05, Revenues Fall Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 subdued as gains in banks offset AI jitters; Dow at one-month high
- Oil heads for weekly gain with focus on Middle East supply
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Price: $0.07 --0%
Financial Fact:
Selling, general and administrative: 1.22M
Today's EPS Names:
OMID, BCBP, BCML, More
Financial Fact:
Selling, general and administrative: 1.22M
Today's EPS Names:
OMID, BCBP, BCML, More
Join SI Premium – FREE
PURE Bioscience, Inc. (NASDAQ: PURE) reported Q3 EPS of ($0.05), versus ($0.05) reported last year. Revenue for the quarter came in at $128.4 thousand, versus $536.5 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prologis (PLD) Tops Q3 EPS by 8c; revises guidance
- Travelers (TRV) Tops Q3 EPS by $1.93, Beats on Revenue
- China Huaren Organic Products, Inc. (CHRN) Tops Q1 EPS by 29c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
